348 related articles for article (PubMed ID: 26203636)
1. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
Milora KA; Fu H; Dubaz O; Jensen LE
J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
[TBL] [Abstract][Full Text] [Related]
2. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
[TBL] [Abstract][Full Text] [Related]
3. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Chemokine Receptor Inhibition in Treating IL-36α-Induced Psoriasiform Inflammation.
Campbell JJ; Ebsworth K; Ertl LS; McMahon JP; Wang Y; Yau S; Mali VR; Chhina V; Kumamoto A; Liu S; Dang T; Newland D; Charo IF; Zhang P; Schall TJ; Singh R
J Immunol; 2019 Mar; 202(6):1687-1692. PubMed ID: 30718298
[TBL] [Abstract][Full Text] [Related]
5. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner.
Alvarez P; Jensen LE
Mediators Inflamm; 2016; 2016():6756138. PubMed ID: 28057979
[TBL] [Abstract][Full Text] [Related]
7. IL-1R1 signaling facilitates Munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation.
Uribe-Herranz M; Lian LH; Hooper KM; Milora KA; Jensen LE
J Invest Dermatol; 2013 Jun; 133(6):1541-9. PubMed ID: 23407395
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis.
Sato S; Chiba T; Nakahara T; Furue M
Australas J Dermatol; 2020 Feb; 61(1):e39-e45. PubMed ID: 31424098
[TBL] [Abstract][Full Text] [Related]
9. IL-36α is involved in hapten-specific T-cell induction, but not local inflammation, during contact hypersensitivity.
Numata T; Yoshizaki T; Yamaguchi S; Shimura E; Iwakura Y; Harada K; Sudo K; Tsuboi R; Nakae S
Biochem Biophys Res Commun; 2018 Nov; 506(3):429-436. PubMed ID: 30352688
[TBL] [Abstract][Full Text] [Related]
10. IL-36α exerts pro-inflammatory effects in the lungs of mice.
Ramadas RA; Ewart SL; Iwakura Y; Medoff BD; LeVine AM
PLoS One; 2012; 7(9):e45784. PubMed ID: 23029241
[TBL] [Abstract][Full Text] [Related]
11. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
[TBL] [Abstract][Full Text] [Related]
12. The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members.
Mattii M; Ayala F; Balato N; Filotico R; Lembo S; Schiattarella M; Patruno C; Marone G; Balato A
Exp Dermatol; 2013 Dec; 22(12):813-9. PubMed ID: 24164463
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines.
Henry CM; Sullivan GP; Clancy DM; Afonina IS; Kulms D; Martin SJ
Cell Rep; 2016 Feb; 14(4):708-722. PubMed ID: 26776523
[TBL] [Abstract][Full Text] [Related]
15. Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammation.
Palmer G; Talabot-Ayer D; Kaya G; Gabay C
J Invest Dermatol; 2007 Aug; 127(8):1938-46. PubMed ID: 17476299
[TBL] [Abstract][Full Text] [Related]
16. IL-33 induces skin inflammation with mast cell and neutrophil activation.
Hueber AJ; Alves-Filho JC; Asquith DL; Michels C; Millar NL; Reilly JH; Graham GJ; Liew FY; Miller AM; McInnes IB
Eur J Immunol; 2011 Aug; 41(8):2229-37. PubMed ID: 21674479
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop.
Hessam S; Sand M; Gambichler T; Skrygan M; Rüddel I; Bechara FG
Br J Dermatol; 2018 Mar; 178(3):761-767. PubMed ID: 28975626
[TBL] [Abstract][Full Text] [Related]
18. Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.
Zhao Z; Zhang R; Gao X; Li H; Liu H
Medicine (Baltimore); 2020 Dec; 99(52):e23832. PubMed ID: 33350771
[TBL] [Abstract][Full Text] [Related]
19. Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients.
Li W; Meng X; Hao Y; Chen M; Jia Y; Gao P
Clin Respir J; 2021 Jun; 15(6):648-656. PubMed ID: 33559376
[TBL] [Abstract][Full Text] [Related]
20. Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB/c mice via suppressing the IL-36α signaling pathway.
Qi Q; Li Q; Zhu H; Lu H; Yang X; Wu Y; Feng C; Fan C; Li H; Wu B; Gao Y; Zhang Z; Zhou H; Zuo J; Tang W
Pharmacol Res; 2021 Jul; 169():105678. PubMed ID: 34015449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
